Sofinnova Venture Partners — 2015 Investments
1 investments dated 2015 · listed companies and verified rows first · show all
Iterum Therapeutics develops anti-infective compounds to treat infections caused by multi-drug resistant pathogens.
BiotechDigital HealthHealthtechMedical DevicesDublin, US
Michael W. Dunne(Executive Officer, Promoter)Corey N. Fishman(Executive Officer, Director, Promoter)Judith M. Matthews(Executive Officer, Promoter)Jeff Schaffnit(Executive Officer)
BoardBrenton K. Ahrens(Director)Ronald M. Hunt(Director)
Board seatJames I. Healy· per SEC Form D · $47.6M raise · filed Dec 2016
Co-investorsBay City CapitalCanaan PartnersSofinnova VenturesFrazier Life Sciences
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.